REFER YOUR COLLEAUGE Register Now

Industry Landscape

Globally, Indian pharma has contributed to improve public health outcomes. India accounts for 60% of global vaccine production, contributing 40 to 70% of the WHO demand for Diphtheria, Tetanus and Pertussis (DPT) and Bacillus Calmette–Guérin (BCG) vaccines, and 90% of the WHO demand for the measles vaccine. Estimates suggest that one in every three pills consumed in the United States is produced by an Indian generics manufacturer. In the UK, approximately 25% of the medicines used are made in India.

Why this Forum

The 9th Edition Global Pharma Regulatory Summit organized by CPhI Conferences will witness a gathering of senior leaders and experts of regulatory affairs, compliances, quality assurance and policy makers to discuss and share their perspectives on current trends and challenges in global regulatory landscape. The themes are designed to inspire and enable the brilliant minds from across the pharma ecosystem to come together to examine, discuss and debate how to improve regulatory system and lower the challenges associated

Who Should Partner

Enterprise Solutions

Regulatory solutions

Legal firms

Pharma consultants

Data management

Software and technology

R&D solution providers

Who Should Attend?

The 9^th Global Pharma Regulatory Summit will bring together leading Regulatory experts and decision makers from across the pharma industry. These delegates will be attending this summit to learn about the latest updates on regulations, best practice and compliance advances in the sector and much more.

The Global Pharma Regulatory Summit is designed for

Designation

VP’s; Directors; HODs

Sr. Managers / General Managers

Managers/ Deputy Managers

Executives

Programme Focus

World renowned speaker sharing their thoughts on current amendments
by USFDA, MHRA, ANVISA and Medicines for Europe

Presentations by industry experts on Price
Regulations, Clinical Trial, etc

In-depth panel discussions on global regulatory updates, Biopharma
growth and regulatory perspectives in India

Overview of Nitrosamines Impurities and current
regulations on Impurity Profiling

Advisory Board Members & Speakers

Abhishek Sinha

Director Global Regulatory Affairs
Advanz Pharma

Dr. Aloka Srinivasan

Principal
RAAHA LLC and Former FDA

Archana Subramanya

EVP & Head GRPD Centers
Poland, India, Egypt and Mexico, Glaxosmithkline Pharmaceuticals Ltd

Dr. BM Rao

Vice President and Head Corporate Quality Control
Dr. Reddy's Laboratories

Dr. Boitumelo Semete-Makokotlela

Chief Executive Officer
South African Health Products Regulatory Authority

Gabriel Ramos Ferronatto

Quality Assessor API Registration Department
ANVISA

Ian Schofield

Executive Editor
Pink Sheet

Keith McDonald

Deputy Director, Licensing Division
Medicines and Healthcare products Regulatory Agency (MHRA)

Dr. M Madan Mohan Reddy

Vice President - Quality and Regulatory
EISAI India

Madhuri Kalwar

Head of Regulatory Affairs, Europe
Advanz Pharma

Parag Nagarkar

Head - Regulatory Affairs
Serum Institute of India

Phil Crooker

Vice President, Technical - Regulatory & Access
Parexel International and Former FDA

Dr. Prasanna Bangale

Vice President & Head - Global Regulatory Affairs
Alembic Pharmaceuticals

Dr. Praveen Kumar L

Director - Regulatory Affairs and Head Medical Device and India Regulatory
Cipla

Rajender Singh

Senior Vice President & Head - Global Regulatory Affairs
Mankind Pharma

Dr. Ranjana B. Pathak

President-Global Quality, Medical Affairs & Pharmacovigilance
Cipla

Rashida Najmi

Senior Vice President - Quality and RA
Piramal Pharma Solutions

Sanjeev Gupta

Sr. General Manager - Advanced Biotech Lab
IPCA Laboratories

Dr. Sarfaraz K. Niazi

Adjunct Professor - University of Illinois and University of Houston and Founder
Karyo Biologics, Adello Biologics and Pharmaceutical Scientist Inc.

VIEW ALL SPEAKERS

Why Attend

Access the latest information and insights on global regulatory affairs program

Analyze how stakeholders around the world are supporting regulatory system optimization

Examine the impact of new initiatives for emerging markets

Network with innovators and opinion leaders in the pharma regulatory affairs arena

Glimpses & Testimonials

Quote The conference helped us in gaining experience from Industry experts on the practical examples shared by the speakers on how these guidelines work actually in the regulatory framework Quote

Vinaya Shenoy
GSK Asia Pvt. Ltd.

Quote Selection of topics & presentations from the industry experts is the key factor which differentiates this conference from others. This is a very professional & well planned event Quote

Mr. Rakesh Jarwekar
Cipla Ltd

Quote GPRS is one of the most important summit for spreading knowledge of regulatory professional. Nice arrangement and more important topics has been discussed by experts Quote

Mr. Md. Aby Kawsar
Eskayef Pharmaceuticals Ltd.